Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SABCS 2024 | Exploring patient-derived xenografts for breast cancer research

Jonathan Lei • 12 Dec 2024
SABCS 2024
Breast Cancer

Jonathan Lei, PhD, Baylor College of Medicine, Houston, TX, describes the utility of patient-derived xenografts (PDX) as a clinically relevant model for studying breast cancer. Researchers can evaluate responses to multiple chemotherapy agents and combinations, which is not feasible in clinical trials. PDX models enable comprehensive testing of treatment strategies and enhance our understanding of chemotherapy efficacy, offering valuable insights for developing tailored therapies in breast cancer care. This interview took place at the 2024 San Antonio Breast Cancer Symposium (SABCS) congress in San Antonio, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Jonathan Lei

Evaluating the clinical significance of PDX models in breast cancer research
0:46
Evaluating the clinical significance of PDX models in breast cancer research
Jonathan Lei • 12 Dec 2024
Biomarker-based chemotherapy optimization for TNBC with PDX models
1:57
Biomarker-based chemotherapy optimization for TNBC with PDX models
Jonathan Lei • 12 Dec 2024

Related Videos

HYPORT: does the number of fractions of RNRT impact the typical symptoms experienced?
1:07
HYPORT: does the number of fractions of RNRT impact the typical symptoms experienced?
Sanjoy Chatterjee • 17 May 2026
QoL following hypofractionated adjuvant breast RNRT: insights from the HYPORT study
1:15
QoL following hypofractionated adjuvant breast RNRT: insights from the HYPORT study
Sanjoy Chatterjee • 17 May 2026
Design and aim of the HYPORT study in regional nodal breast cancer
1:23
Design and aim of the HYPORT study in regional nodal breast cancer
Sanjoy Chatterjee • 17 May 2026
Adherence to weight loss intervention in breast cancer patients
1:09
Adherence to weight loss intervention in breast cancer patients
Jennifer Ligibel • 31 May 2026
The content of VJOncology is intended for healthcare professionals